Follow
Athanasios G. Tzioufas
Athanasios G. Tzioufas
Professor of Rheumatology, Medical School, National and Kapodistrian University of Athens
Verified email at med.uoa.gr
Title
Cited by
Cited by
Year
Classification criteria for Sjögren’s syndrome
C Vitali, N Del Papa
Sjögren's Syndrome, 47-60, 2016
63472016
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
JS Smolen, FC Breedveld, GR Burmester, V Bykerk, M Dougados, ...
Annals of the rheumatic diseases 75 (1), 3-15, 2016
16252016
EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome
R Seror, P Ravaud, SJ Bowman, G Baron, A Tzioufas, E Theander, ...
Annals of the rheumatic diseases 69 (6), 1103-1109, 2010
9662010
Sjögren syndrome
P Brito-Zerón, C Baldini, H Bootsma, SJ Bowman, R Jonsson, X Mariette, ...
Nature reviews Disease primers 2 (1), 1-20, 2016
7212016
EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome
R Seror, P Ravaud, X Mariette, H Bootsma, E Theander, A Hansen, ...
Annals of the rheumatic diseases 70 (6), 968-972, 2011
545*2011
Treatment of primary Sjögren syndrome: a systematic review
M Ramos-Casals, AG Tzioufas, JH Stone, A Sisó, X Bosch
Jama 304 (4), 452-460, 2010
4842010
EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies
M Ramos-Casals, P Brito-Zerón, S Bombardieri, H Bootsma, S De Vita, ...
Annals of the rheumatic diseases 79 (1), 3-18, 2020
4402020
Primary Sjögren’s syndrome: new clinical and therapeutic concepts
M Ramos-Casals, AG Tzioufas, J Font
Annals of the rheumatic diseases 64 (3), 347-354, 2005
4382005
High prevalence of anti-cardiolipin and other autoantibodies in a healthy elderly population.
MN Manoussakis, AG Tzioufas, MP Silis, PJ Pange, J Goudevenos, ...
Clinical and experimental immunology 69 (3), 557, 1987
4381987
Single-cell analysis of human mononuclear phagocytes reveals subset-defining markers and identifies circulating inflammatory dendritic cells
CA Dutertre, E Becht, SE Irac, A Khalilnezhad, V Narang, S Khalilnezhad, ...
Immunity 51 (3), 573-589. e8, 2019
3872019
EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
R Seror, SJ Bowman, P Brito-Zeron, E Theander, H Bootsma, A Tzioufas, ...
RMD open 1 (1), e000022, 2015
3212015
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient …
R Seror, H Bootsma, A Saraux, SJ Bowman, E Theander, JG Brun, ...
Annals of the rheumatic diseases 75 (2), 382-389, 2016
3142016
Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross‐reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome
AG Tzioufas, DS Boumba, FN Skopouli, HM Moutsopoulos
Arthritis & Rheumatism 39 (5), 767-772, 1996
3061996
Anaemia in systemic lupus erythematosus: from pathophysiology to clinical assessment
S Giannouli, M Voulgarelis, PD Ziakas, AG Tzioufas
Annals of the rheumatic diseases 65 (2), 144-148, 2006
3052006
Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements
M Ramos-Casals, P Brito-Zerón, R Seror, H Bootsma, SJ Bowman, ...
Rheumatology 54 (12), 2230-2238, 2015
3032015
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
R Seror, E Theander, JG Brun, M Ramos-Casals, V Valim, T Dörner, ...
Annals of the rheumatic diseases 74 (5), 859-866, 2015
3012015
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid …
GR Burmester, X Mariette, C Montecucco, I Monteagudo-Sáez, M Malaise, ...
Annals of the rheumatic diseases 66 (6), 732-739, 2007
2912007
Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome
M Voulgarelis, AG Tzioufas
Nature Reviews Rheumatology 6 (9), 529-537, 2010
2902010
Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome
A Goules, S Masouridi, AG Tzioufas, JPA Ioannidis, FN Skopouli, ...
Medicine 79 (4), 241-249, 2000
2792000
The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome
DI Mitsias, AG Tzioufas, C Veiopoulou, E Zintzaras, IK Tassios, ...
Clinical & Experimental Immunology 128 (3), 562-568, 2002
2542002
The system can't perform the operation now. Try again later.
Articles 1–20